LIP
ABUS icon

Lighthouse Investment Partners’s Arbutus Biopharma ABUS Stock Holding History

Lighthouse Investment Partners’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-99,055
Closed -$256K – 383
2024
Q1 		$256K Buy
+99,055
New +$257K 0.01% 356

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lighthouse Investment Partners's ABUS Position: Q2 2024 in Review

Lighthouse Investment Partners sold out of Arbutus Biopharma (ABUS) in Q2 2024, closing a stake of 99,055 shares — an estimated $256K sold.

Lighthouse Investment Partners first reported a position in ABUS in Q1 2024 and held it in 1 quarter. The position peaked at $256K in Q1 2024. 131 funds tracked by Wall St. Rank hold ABUS as of Q2 2024.

  • Lighthouse Investment Partners reported no remaining Arbutus Biopharma position as of Q2 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 99,055 Arbutus Biopharma shares in Q2 2024, an estimated $256K.
  • Lighthouse Investment Partners first reported a position in Arbutus Biopharma in Q1 2024 and held it in 1 quarter.
  • Lighthouse Investment Partners's Arbutus Biopharma position peaked at $256K in Q1 2024.
  • 131 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2024.

Based on Lighthouse Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.